Evaluating Different Physician's Prescribing Preference Based Instrumental Variables in the Study of Beta2-Agonist Use and the Risk of Acute Myocardial Infarction

被引：0
|
作者：
Uddin, Md Jamal [1 ]
Groenwold, Rolf H. H. [1 ,2 ]
de Boer, Anthonius [1 ]
Afonso, Ana [1 ]
Primatesta, Paola [3 ]
Becker, Claudia [4 ]
Belitser, Svetlana V. [1 ]
Hoes, Arno W. [2 ]
Roes, Kit C. B. [2 ]
Klungel, Olaf H. [1 ]
机构：
[1] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[3] Novartis Pharma AG, Global Epidemiol, Basel, Switzerland
[4] Univ Basel, Div Clin Pharm & Epidemiol, Basel Pharmacoepidemiol Unit, Basel, Switzerland
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
58
引用
收藏
页码：32 / 32
页数：1
相关论文
共 11 条
  • [1] Evaluating different physician's prescribing preference based instrumental variables in two primary care databases: a study of inhaled long-acting beta2-agonist use and the risk of myocardial infarction
    Uddin, Md. Jamal
    Groenwold, Rolf H. H.
    de Boer, Anthonius
    Afonso, Ana S. M.
    Primatesta, Paola
    Becker, Claudia
    Belitser, Svetlana V.
    Hoes, Arno W.
    Roes, Kit C. B.
    Klungel, Olaf H.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 132 - 141
  • [2] Application of Instrumental Variables Method in Pharmacoepidemiology: An Example of Beta2-Agonist Use and Myocardial Infarction
    Uddin, M. Jamal
    Groenwold, Rolf H. H.
    de Boer, Anthonius
    Belitser, Svetlana V.
    Hoes, Arno W.
    Roes, Kit C. B.
    Klungel, Olaf H.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 32 - 33
  • [3] Short-Acting Beta2-Agonist Use in Asthma in Korea: A 10-Year Population-Based Study
    Lee, Hyun
    Ryu, Jiin
    Chung, Sung Jun
    Yeo, Yoomi
    Park, Tai Sun
    Park, Dong Won
    Moon, Ji-Yong
    Kim, Tae-Hyung
    Sohn, Jang Won
    Yoon, Ho Joo
    Kim, Sang-Heon
    [J]. ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2021, 13 (06) : 945 - 953
  • [4] Evidence for no association between use of beta-2-agonists and risk of acute myocardial infarction in patients with hypertension
    de Vries, Frank
    Pouwels, Sander
    Bracke, Madelon
    Klungel, Olaf
    Lammers, Jan-Willem
    Leufkens, Hubert
    van Staa, Tjeerd
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S40 - S40
  • [5] Relationship Between Zolpidem Use and Acute Myocardial Infarction Risk: A Taiwanese Population-Based Case-Control Study
    Lin, Yen-Nien
    Ko, Po-Yen
    Chang, Chih-Ping
    Yang, Chen-Chia
    Lin, Jen-Jyh
    [J]. CIRCULATION, 2013, 128 (22)
  • [6] Beta-blocker use and risk of acute exacerbations of COPD following first-time myocardial infarction. A Danish nationwide cohort study
    Rasmussen, Daniel
    Bodtger, Uffe
    Lamberts, Morten
    Lange, Peter
    Jensen, Magnus
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [7] Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study
    Tsai, Ching-Piao
    Lin, Feng-Cheng
    Lee, Charles Tzu-Chi
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (12) : 1593 - 1601
  • [8] Long-Term Cardiovascular Risk in Type 2 Diabetic Compared With Nondiabetic First Acute Myocardial Infarction Patients A population-based cohort study in southern Europe
    Francisco Cano, J.
    Baena-Diez, Jose M.
    Franch, Josep
    Vila, Joan
    Tello, Susana
    Sala, Joan
    Elosua, Roberto
    Marrugat, Jaume
    [J]. DIABETES CARE, 2010, 33 (09) : 2004 - 2009
  • [9] Risk of new acute myocardial infarction hospitalization associated with use of oral and parenteral non-steroidal anti-inflammation drugs (NSAIDs): a case-crossover study of Taiwan's National Health Insurance claims database and review of current evidence
    Wen-Yi Shau
    Hsi-Chieh Chen
    Shu-Ting Chen
    Hsu-Wen Chou
    Chia-Hsuin Chang
    Chuei-Wen Kuo
    Mei-Shu Lai
    [J]. BMC Cardiovascular Disorders, 12
  • [10] Risk of new acute myocardial infarction hospitalization associated with use of oral and parenteral non-steroidal anti-inflammation drugs (NSAIDs): a case-crossover study of Taiwan's National Health Insurance claims database and review of current evidence
    Shau, Wen-Yi
    Chen, Hsi-Chieh
    Chen, Shu-Ting
    Chou, Hsu-Wen
    Chang, Chia-Hsuin
    Kuo, Chuei-Wen
    Lai, Mei-Shu
    [J]. BMC CARDIOVASCULAR DISORDERS, 2012, 12
12